WXSH-0150

N/A

Report date: 2025/06/05 16:57:34
NME

Base Information

Drug NameWXSH-0150
Drug Alias NameWXSH-0150TUL-01101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitorsTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase 2Tyrosine-protein kinase JAK2
Therapy Area/IndicationsDermatitis, AtopicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhuhai United Laboratories Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhuhai United Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsDermatitis, AtopicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A